(Q35748117)

10 August 2017

1 reference

title

HIV prevention, cost-utility analysis, and race/ethnicity: methodological considerations and recommendations (English)

1 reference

10 August 2017

main subject

prevention of HIV/AIDS

0 references

author name string

David R Holtgrave

series ordinal

1

1 reference

10 August 2017

language of work or name

1 reference

1 March 2004

1 reference

10 August 2017

published in

Medical Decision Making

1 reference

10 August 2017

volume

24

1 reference

10 August 2017

issue

2

1 reference

10 August 2017

page(s)

181-191

1 reference

Reconstruction and future trends of the AIDS epidemic in the United States

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0272989X04263342

Meta-analysis of the effectiveness of HIV prevention interventions for women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X04263342

Cost-effectiveness of a brief video-based HIV intervention for African American and Latino sexually transmitted disease clinic clients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X04263342

Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X04263342

Economic evaluation of HIV prevention programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X04263342

The 'fair innings argument' deserves a fairer hearing! Comments by Alan Williams on Nord and Johannesson.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X04263342

Cost-effectiveness analysis in a setting of budget constraints--is it equitable?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X04263342

When drug treatment in the elderly is not cost effective. An ethical dilemma in an environment of healthcare rationing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X04263342

Effectiveness of an intervention to reduce HIV transmission risks in HIV-positive people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X04263342

Cost-effectiveness of HIV-prevention skills training for men who have sex with men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X04263342

Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X04263342

Taking antiretroviral therapy for HIV infection: learning from patients' stories

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X04263342

Assessing the health of the nation. The predictive validity of a preference-based measure and self-rated health

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X04263342

Racial differences in patients' perceptions of debilitated health states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X04263342

Black-white differences in health status: methods or substance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X04263342

Does decision analysis have a race problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X04263342

Cost-effectiveness analysis, extended dominance, and ethics: a quantitative assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X04263342

Modeling age differences in cost-effectiveness analysis. A review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X04263342

Equity in the allocation of health care resources.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X04263342

21 January 2018

Identifiers

DOI

10.1177/0272989X04263342

1 reference

10 August 2017

1 reference